Conavi Medical Corp.
CNVI.V
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -41.31% | 485.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -41.31% | 485.71% | |||
| Cost of Revenue | -- | 3,328.57% | |||
| Gross Profit | -35.51% | 441.29% | |||
| SG&A Expenses | 47.74% | 27.69% | |||
| Depreciation & Amortization | -8.13% | -1.02% | |||
| Other Operating Expenses | 2,101.72% | -- | |||
| Total Operating Expenses | -2.83% | 16.73% | |||
| Operating Income | 0.06% | -10.35% | |||
| Income Before Tax | 60.67% | -91.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 60.67% | -91.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 60.67% | -91.68% | |||
| EBIT | 0.06% | -10.35% | |||
| EBITDA | -0.17% | -10.64% | |||
| EPS Basic | 60.41% | -69.95% | |||
| Normalized Basic EPS | 60.40% | -69.79% | |||
| EPS Diluted | 60.41% | -69.95% | |||
| Normalized Diluted EPS | 60.40% | -69.79% | |||
| Average Basic Shares Outstanding | -0.57% | 12.63% | |||
| Average Diluted Shares Outstanding | -0.57% | 12.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||